Form 8-K - Current report:
SEC Accession No. 0000353569-20-000007
Filing Date
2020-01-10
Accepted
2020-01-09 18:36:16
Documents
16
Period of Report
2020-01-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K preliminaryrevenueq419.htm   iXBRL 8-K 51765
2 EXHIBIT 99.1 exhibit991.htm EX-99.1 22674
8 qdel8k20image1a20.jpg GRAPHIC 11058
  Complete submission text file 0000353569-20-000007.txt   277984

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qdel-20200109.xsd EX-101.SCH 4660
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT qdel-20200109_cal.xml EX-101.CAL 697
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qdel-20200109_def.xml EX-101.DEF 16036
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qdel-20200109_lab.xml EX-101.LAB 33521
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qdel-20200109_pre.xml EX-101.PRE 17564
18 EXTRACTED XBRL INSTANCE DOCUMENT preliminaryrevenueq419_htm.xml XML 5040
Mailing Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Business Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 8585521100
QUIDEL CORP /DE/ (Filer) CIK: 0000353569 (see all company filings)

EIN.: 942573850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-10961 | Film No.: 20519141
SIC: 2835 In Vitro & In Vivo Diagnostic Substances